Point72 Middle East Fze Ultragenyx Pharmaceutical Inc. Transaction History

Point72 Middle East Fze

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$34.92 - $46.66 $539,898 - $721,410
-15,461 Reduced 68.1%
7,243 $258,000
Q2 2023

Aug 14, 2023
BUY
$37.35 - $52.15 $763,321 - $1.07 Million
20,437 Added 901.5%
22,704 $1.05 Million
Q1 2023

May 15, 2023
BUY
$36.99 - $48.71 $66,175 - $87,142
1,789 Added 374.27%
2,267 $90,000
Q4 2022

Feb 14, 2023
BUY
$33.72 - $46.33 $16,118 - $22,145
478 New
478 $0

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.5M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.01B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email